neuropacs™ Corp.

About neuropacs™ Corp.

neuropacs™ is a company focused on accelerating the development of disease-modifying therapies for neurodegenerative diseases through AI-powered, imaging-enabled software. Their mission is to provide precise diagnostic insights and patient stratification tools for clinical trials, aiming to improve diagnostic accuracy, reduce trial costs, and bring treatments to patients faster.

Products & Services

AIDP:An imaging biomarker tool for neurodegenerative disease diagnostics.

Clinical Trials Support:Tools and services to optimize clinical trial outcomes with precision diagnostics.

Diagnostics:Comprehensive diagnostic solutions for neurodegenerative diseases.

Specialties

AI-driven diagnostics Neurodegenerative disease imaging Clinical trial optimization Free-Water Imaging (FWI) Precision diagnostics for Parkinson's, Alzheimer's, and other neurodegenerative conditions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 1000000 MR: - FA: over $1.0 million FAN: 1000000	D: 2026-01-20 FD: 2026-01-20	1 investors

Seed Latest

2026-01-20

$1.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Charles H. Adler

MD, PhD

R

Reza Forghani

MD, PhD

D

David R. Nelson

MD

M

Michael S. Okun

Director, Fixel Institute

J

Jill Ostrem

MD

A

Adolfo Ramirez-Zamora

MD

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

neuropacs™ Corp. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised